SUSQUEHANNA INTERNATIONAL GROUP, LLP - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 80 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$2,487,312
+33.5%
492,537
+33.0%
0.00%
Q2 2023$1,862,871
-33.7%
370,352
-19.0%
0.00%
Q1 2023$2,811,645
-64.9%
457,178
-24.8%
0.00%
-100.0%
Q4 2022$8,021,152
+604.2%
607,663
+58.5%
0.00%
Q3 2022$1,139,000
-39.4%
383,293
-25.6%
0.00%
Q2 2022$1,881,000
-17.8%
515,400
+39.5%
0.00%
Q1 2022$2,287,000
-64.7%
369,590
-53.8%
0.00%
Q4 2021$6,478,000
-25.2%
799,800
+37.7%
0.00%
-100.0%
Q3 2021$8,657,000
+41.2%
580,978
+19.0%
0.00%
Q2 2021$6,129,000
+5908.8%
488,331
+3438.6%
0.00%
Q1 2019$102,00013,8000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders